MX9700152A - Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol. - Google Patents
Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol.Info
- Publication number
- MX9700152A MX9700152A MX9700152A MX9700152A MX9700152A MX 9700152 A MX9700152 A MX 9700152A MX 9700152 A MX9700152 A MX 9700152A MX 9700152 A MX9700152 A MX 9700152A MX 9700152 A MX9700152 A MX 9700152A
- Authority
- MX
- Mexico
- Prior art keywords
- omeprazole
- magnesium salt
- oral pharmaceutical
- pharmaceutical formulation
- formulation containing
- Prior art date
Links
- SUBDBMMJDZJVOS-UHFFFAOYSA-N 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole Chemical compound N=1C2=CC(OC)=CC=C2NC=1S(=O)CC1=NC=C(C)C(OC)=C1C SUBDBMMJDZJVOS-UHFFFAOYSA-N 0.000 title abstract 2
- 159000000003 magnesium salts Chemical class 0.000 title abstract 2
- 229960000381 omeprazole Drugs 0.000 title abstract 2
- 239000008203 oral pharmaceutical composition Substances 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 1
- 239000002702 enteric coating Substances 0.000 abstract 1
- 238000009505 enteric coating Methods 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9400679 | 1994-07-08 | ||
| PCT/SE1995/000816 WO1996001622A1 (en) | 1994-07-08 | 1995-07-03 | New oral pharmaceutical formulation containing magnesium salt of omeprazole |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9700152A true MX9700152A (es) | 1997-04-30 |
Family
ID=20393105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9700152A MX9700152A (es) | 1994-07-08 | 1995-07-03 | Nueva formulacion farmaceutica oral, que contiene sal de magnesio de omeprazol. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0768872A1 (cs) |
| KR (1) | KR970704426A (cs) |
| BR (1) | BR9508261A (cs) |
| CA (1) | CA2193681A1 (cs) |
| CZ (1) | CZ379596A3 (cs) |
| EE (1) | EE03378B1 (cs) |
| FI (1) | FI970058L (cs) |
| HU (1) | HUT78132A (cs) |
| IS (1) | IS4398A (cs) |
| MX (1) | MX9700152A (cs) |
| NO (1) | NO970036L (cs) |
| NZ (1) | NZ289958A (cs) |
| PL (1) | PL181265B1 (cs) |
| SK (1) | SK281803B6 (cs) |
| WO (1) | WO1996001622A1 (cs) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9500478D0 (sv) * | 1995-02-09 | 1995-02-09 | Astra Ab | New pharmaceutical formulation and process |
| US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
| US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
| US5900258A (en) * | 1996-02-01 | 1999-05-04 | Zeolitics Inc. | Anti-bacterial compositions |
| SI9700186B (sl) | 1997-07-14 | 2006-10-31 | Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. | Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin |
| US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
| SE9704870D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulation I |
| US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
| SE9802973D0 (sv) | 1998-09-03 | 1998-09-03 | Astra Ab | Immediate release tablet |
| US6316020B1 (en) * | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
| EP1133987A1 (en) * | 2000-03-09 | 2001-09-19 | Ian Whitcroft | Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor |
| EP1263445A1 (en) * | 2000-03-09 | 2002-12-11 | Ian Whitcroft | Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin, metronidazole and a gastrointestinal hydrogen pump inhibitor |
| EP1552833B1 (en) * | 2002-10-16 | 2016-12-28 | Takeda Pharmaceutical Company Limited | Process for producing an amorphous optically active isomer of lansoprazole |
| US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| EP1755566A2 (en) * | 2004-06-15 | 2007-02-28 | Teva Pharmaceutical Industries Ltd | Stable pharmaceutical formulations of benzimidazole compounds |
| CN105106168B (zh) * | 2015-08-19 | 2018-03-06 | 德州德药制药有限公司 | 一种埃索美拉唑镁肠胶囊及其制备方法 |
| WO2022144785A1 (en) * | 2020-12-30 | 2022-07-07 | Hk Inno.N Corporation | Pharmaceutical composition comprising tegoprazan and non-steroidal anti-inflammatory drugs |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
| JPH0768125B2 (ja) * | 1988-05-18 | 1995-07-26 | エーザイ株式会社 | 酸不安定化合物の内服用製剤 |
| SE9302395D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | New pharmaceutical formulation |
| SE9302396D0 (sv) * | 1993-07-09 | 1993-07-09 | Ab Astra | A novel compound form |
-
1995
- 1995-07-03 CA CA002193681A patent/CA2193681A1/en not_active Abandoned
- 1995-07-03 EE EE9700014A patent/EE03378B1/xx not_active IP Right Cessation
- 1995-07-03 MX MX9700152A patent/MX9700152A/es unknown
- 1995-07-03 HU HU9700039A patent/HUT78132A/hu unknown
- 1995-07-03 BR BR9508261A patent/BR9508261A/pt not_active Application Discontinuation
- 1995-07-03 FI FI970058A patent/FI970058L/fi unknown
- 1995-07-03 SK SK1660-96A patent/SK281803B6/sk unknown
- 1995-07-03 WO PCT/SE1995/000816 patent/WO1996001622A1/en not_active Ceased
- 1995-07-05 PL PL95318464A patent/PL181265B1/pl unknown
- 1995-07-05 NZ NZ289958A patent/NZ289958A/en unknown
- 1995-07-05 EP EP95926067A patent/EP0768872A1/en not_active Withdrawn
- 1995-07-05 CZ CZ963795A patent/CZ379596A3/cs unknown
- 1995-07-05 KR KR1019970700059A patent/KR970704426A/ko not_active Ceased
-
1996
- 1996-12-17 IS IS4398A patent/IS4398A/is unknown
-
1997
- 1997-01-06 NO NO970036A patent/NO970036L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUT78132A (hu) | 2000-06-28 |
| IS4398A (is) | 1996-12-17 |
| WO1996001622A1 (en) | 1996-01-25 |
| FI970058A7 (fi) | 1997-01-07 |
| EE9700014A (et) | 1997-06-16 |
| EE03378B1 (et) | 2001-04-16 |
| EP0768872A1 (en) | 1997-04-23 |
| PL318464A1 (en) | 1997-06-09 |
| NO970036D0 (no) | 1997-01-06 |
| FI970058A0 (fi) | 1997-01-07 |
| WO1996001622A8 (en) | 1999-12-23 |
| NO970036L (no) | 1997-01-06 |
| AU695723B2 (en) | 1998-08-20 |
| PL181265B1 (pl) | 2001-06-29 |
| BR9508261A (pt) | 1997-12-23 |
| SK281803B6 (sk) | 2001-08-06 |
| FI970058L (fi) | 1997-01-07 |
| SK166096A3 (en) | 1997-09-10 |
| AU2994795A (en) | 1996-02-09 |
| NZ289958A (en) | 1998-09-24 |
| HU9700039D0 (en) | 1997-02-28 |
| CA2193681A1 (en) | 1996-01-25 |
| KR970704426A (ko) | 1997-09-06 |
| CZ379596A3 (en) | 1997-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2191682T3 (es) | Nueva formulacion farmaceutica. | |
| AR002275A1 (es) | Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral. | |
| GR910100283A (el) | Στερεά από του στόματος χορηγουμένη φαρμακευτική μορφή δοσιμετρήσεως προγραμματισμένου ρυ?μού απελευ?ερώσεως. | |
| ES2157297T3 (es) | Granulos entericos de duloxetina. | |
| ES2180251T3 (es) | Comprimido revestido con polimero, que contiene amoxicilina y clavulanato. | |
| NO970036L (no) | Nytt oralt, farmasöytisk preparat inneholdende magnesiumsalt av omeprazol | |
| CY1106072T1 (el) | Φαρμακευτικη μορφη δοσης παρατεταμενης αποδεσμευσης απο του στοματος | |
| CA2170647A1 (en) | Multiple unit tableted dosage form i | |
| DE69805001D1 (de) | Osmotische darreichungsform mit zwei mantelschichten | |
| EP1123087A4 (en) | ORAL SYSTEM FOR THE ADMINISTRATION OF PULSED DOSES OF A MEDICAMENT | |
| CA2147606A1 (en) | Stable Extended Release Oral Dosage Composition | |
| FR2653338B1 (fr) | Formulation pour des pansements a liberation prolongee de medicament et son utilisation. | |
| FI891921A0 (fi) | Menetelmä oraalisen antosysteemin valmistamiseksi | |
| ITMI922192A1 (it) | Compressa per impiego terapeutico atta a cedere una o piu' sostanze attive con differenti velocita' | |
| DE69909316D1 (de) | Pharmazeutische formulierung mit omeprazol | |
| CO5611097A2 (es) | Tableta farmaceutica | |
| CY1107909T1 (el) | Πολυστρωματικο δισκιο περιεχον ροσιγλιταζονη | |
| AR008176A1 (es) | Forma de dosificacion oral de liberacion controlada y uso de la misma para la fabricacion de medicamentos | |
| EE9600018A (et) | 2,9-diasendatud puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| FI941447A0 (fi) | Suun kautta annettavat, kapseleina olevat ubidekarenonivalmisteet | |
| DE60005438D1 (de) | Ein NSAID und Misoprostol enthaltende Arzneitablette | |
| EE9600020A (et) | 9-asendatud 2-(2-n-alkoksüfenüül)puriin-6-oonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid | |
| ES2063432T3 (es) | Compuestos farmaceuticos orales de dosis unitaria. | |
| AR011437A1 (es) | Composicion farmaceutica para el tratamiento de la migrana y el uso de la misma en la preparacion de un medicamento. | |
| ES551785A0 (es) | Un procedimiento para revestir articulos con una composicion de resina formadora de pelicula. |